Cannabis Law Report

SEPTEMBER 15, 2022

Thompson Coburn LLP has released its latest state-by-state ranking of state cannabis regulations. The guide provides a holistic review of the current cannabis laws in every state including the District of Columbia, from favorable to cannabis businesses to most restrictive. Barry Weisz.

Recreational 52

Recreational Legislation Research and Development Retail 52

Cannabis Law Report

JANUARY 28, 2022

IIP) (NYSE: IIPR) today announced the tax treatment of its 2021 distributions as follows: Security Description: Common Stock. 01/14/2022. 01/14/2022. allocable to 2022 for federal income tax purposes. SAN DIEGO–(BUSINESS WIRE)– $IIPR #Dividendstocks –Innovative Industrial Properties, Inc. Record Date.

Treatment 52

Treatment Business Cannabis 52

Veriheal

JULY 9, 2021

Amid the hype of legalization in Connecticut, a cannabis addiction study conducted almost 40 miles away is delivering fascinating results. According to Yale University Professor of Psychiatry Cyril Desouza, where the study was carried out, approximately three out of 10 people are developing a cannabis use disorder.

Treatment 52

Treatment Research and Development Consumption Sleep 52

Cannabis Law Report

AUGUST 23, 2021

Phase II clinical trial of the Satipharm CBD capsules showed significantly reduced monthly seizure frequency in the treatment of children suffering from refractory, or treatment-resistant epilepsy when the Satipharm capsules were added to current medications. following 12 weeks of treatment.

Clinical Trials 105

Clinical Trials CBD Epilepsy Treatment 105

Project CBD

JUNE 7, 2023

Project CBD recently reported on studies indicating that cannabis terpenes — the compounds that give the plant its robust and distinctive smell — activate the CB1 cannabinoid receptor. Medical scientists are studying beta-caryophyllene as a treatment for non-alcoholic fatty liver disease, chronic pain, and substance abuse.

Terpenes 227

Terpenes Chronic Pain Cannabinoids Food 227

Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis. .

Therapy 52

Therapy Treatment Clinical Trials Access 52

TheAnswerPage

AUGUST 26, 2022

This question begins “The Answer of the Day” series on the treatment effects of cannabinoids…. Note: For this entire series, keep in mind that synthetically manufactured medical cannabinoids and plant-derived medical cannabis products may have different pharmacological modes of action and different pharmacokinetics.).

Cannabinoids 52

Cannabinoids Epilepsy Treatment Conditions 52

Veriheal

JANUARY 12, 2024

In January 2022, a devastating incident shook the U.S. cannabis cultivation industry. This marked a somber milestone: the first known asthma-related death in the nation’s cannabis production sector. Here’s what happened and what it could mean for the future of cannabis cultivation safety. In May 2021, Lorna L.

Conditions 112

Conditions Cultivation Safety Advocacy 112

Veriheal

APRIL 6, 2024

Thailand’s newly elected government is looking to reverse its historic decriminalization of cannabis. The announcement comes a short 18 months after it became the first Asian country to decriminalize cannabis back in June 2022. In fact, The Thai Chamber of Commerce estimated cannabis sector would be worth 1.2

Decriminalization 101

Decriminalization Recreational Cannabis Hemp 101

TheAnswerPage

FEBRUARY 26, 2022

Have any states legalized the use of cannabis for medicinal purposes since the start of 2022? states in legalizing marijuana for medical use in February, 2022. Yes, Mississippi joined 36 other U.S.

Treatment 52

Treatment Legislation Conditions Medicine 52

Cannabis Law Report

JULY 13, 2022

Here’s what they posted 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. Ensure compliance with the requirements of the Therapeutic Goods Act 1989 across the medicinal cannabis industry.

Compliance 52

Compliance Compliance Wellness and Beauty Vaping 52

TheAnswerPage

AUGUST 27, 2022

“The Answer of the Day” series on the treatment effects of cannabinoids continues… According to randomized controlled trials, which health conditions does dronabinol (Marinol – a synthetic THC product) effectively treat? BMC Med 20, 259 (2022). Spanagel, R. See the Answer.

Chronic Pain 52

Chronic Pain Cannabinoids Treatment THC 52

TheAnswerPage

AUGUST 28, 2022

“The Answer of the Day” series on the treatment effects of cannabinoids continues… According to randomized controlled trials, which health conditions does nabiximols (Sativex – ~50:50 THC:CBD plant-derived product) effectively treat? BMC Med 20, 259 (2022). Spanagel, R. See the Answer.

Chronic Pain 52

Chronic Pain Therapy Sleep Cannabinoids 52

TheAnswerPage

JULY 2, 2022

” NOTE: Unlike opioid medications, cannabis-based products do NOT cause respiratory depression. for the Treatment of Known or Suspected Overdose with Natural or Synthetic Opioids. for the Treatment of Known or Suspected Overdose with Natural or Synthetic Opioids. June 21, 2022. See the Answer.

Treatment 52

Treatment Safety Patients Cannabis 52

TheAnswerPage

JULY 3, 2022

Note: Unlike opioid medications, cannabis-based products do not cause respiratory depression.). for the Treatment of Known or Suspected Overdose with Natural or Synthetic Opioids. June 21, 2022. Opioid antagonists are used for the complete or partial reversal of opioid drug effects, including respiratory depression.

Treatment 52

Treatment Cannabis 52

Cannabis Law Report

FEBRUARY 9, 2022

Cybin plans to submit a clinical trial application for a pilot study of CYB004 in the second quarter of calendar year 2022 and expects to initiate the pilot study in the third quarter of calendar year 2022.

Treatment 52

Treatment Clinical Trials Research and Development 52

Cannabis Law Report

OCTOBER 1, 2021

TD-0148A is currently in preclinical pharmacology and other IND-enabling studies and in 2022, BetterLife will file its IND and start Phases 1 and 2 in healthy subjects for major depressive disorder. BetterLife is already in advanced stages of GMP manufacturing TD-0148A and initiated the necessary preclinical IND-enabling studies for TD-0148A.

Treatment 52

Treatment Conditions Media 52

Cannabis Law Report

MAY 18, 2022

Wednesday 18 May 2022. This will include the classification system and the different approaches to different types of drugs including psychoactive substances and cannabis-based products. It will consider the potential harms and benefits of controlled drugs, and the treatments available for drug addiction and whether they are adequate.

Policy 52

Policy Treatment Legislation Access 52

Veriheal

NOVEMBER 21, 2023

Veriheal remains dedicated to supporting the next generation of pioneers through its Innovation in Cannabis Scholarship. As we reflect on the success of the 2022 recipients, we are thrilled to introduce the exceptional winners of the 2023 scholarship. Maya worked with a group of her peers to develop the buddie Bluetooth cannabis bowl.

Research and Development 107

Research and Development Consumption Education Data 107

Veriheal

JANUARY 26, 2023

According to recent research, cannabis could offer unique benefits as part of an approach to managing bipolar disorder. In this article, we’ll explore how the potential advantages of cannabis might help stabilize symptoms associated with bipolar disorder. Most commonly, pharmaceutical medication is prescribed to regulate moods.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

TheAnswerPage

APRIL 3, 2022

“As pediatric cancers differ greatly from adult ones, … any anti-cancer therapy, including cannabis, may act differently in children compared to adults. Medical Cannabis in Pediatric Oncology: Friend or Foe? Pharmaceuticals 2022, 15, 359. ” Malach, M.; Kovalchuk, I.; Kovalchuk, O. link] ph15030359.

Therapy 52

Therapy Research and Development Pharmaceutical Cannabinoids 52

Veriheal

MARCH 23, 2024

In a historic move, Ukraine’s government has legalized medical cannabis. Now, medical cannabis is seen as a way to help those suffering. The Parliamentary Vote for Legal Cannabis in Ukraine The vote in Ukraine’s parliament was a pivotal moment. It controls how cannabis is produced and given out.

Legalization 109

Legalization Chronic Pain Sleep Policy 109

TheAnswerPage

JULY 17, 2022

In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Their findings included the following: “The average daily dose ranged between 1 and 50 mg/kg, with treatment length from 3 to 12 months (mean 6.2 12 September 2018.

Epilepsy 72

Epilepsy Extraction Treatment CBD 72

Veriheal

JANUARY 24, 2023

As cannabis enthusiasts, we’re all too familiar with the stigma surrounding its use and the hoops that have to be jumped through to get it into medical research trials. In light of this, one has to ask: Why isn’t cannabis also being considered ? So what gives? In the saga of prohibition, here’s the latest news.

DEA 98

DEA Treatment Medicine Pets 98

Veriheal

JUNE 14, 2023

A report was released by the Marijuana Policy Project (MPP) on May 1 on the combined sale of cannabis across the U.S. Since the state-legal, adult-use cannabis market began in 2014, a combined total of more than $15 billion has been generated in tax revenue. The revenue generated in 2022 alone was $3.77

Recreational 98

Recreational Legalization Cannabis Packaging 98

Cannabis Law Report

APRIL 14, 2022

Cannabis cultivation and processing are rapidly-growing industries, as hemp and both recreational and medical marijuana products are being legalized across the country. by eating or smoking cannabis) are unknown. Since growing cannabis has not always been legal, growers did not always choose pesticides that were “approvable” by EPA.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

DECEMBER 21, 2021

This UK-based company caught our attention in 2021 for its team of renowned psychedelic researchers, including chief research officer Professor David Nutt, chief medical officer Dr. Ben Sessa, and head of ketamine psychotherapy Dr. Celia Morgan, as well as its unique studies into ketamine treatment for addiction and gambling addiction.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Cannabis Law Report

JANUARY 24, 2022

DUBLIN–(BUSINESS WIRE)–The “North America Legal Cannabis Market Size, Share & Trends Analysis Report by Sources (Marijuana, Hemp), by Derivatives (CBD, THC), by End Use (Medical, Recreational), and Segment Forecasts, 2022-2028” report has been added to ResearchAndMarkets.com’s offering.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Leafwell

JANUARY 11, 2022

Only about 37 percent of people afflicted with anxiety receive treatment. According to the Anxiety and Depression Association of America (ADAA), 40 million U.S. adults grapple with anxiety disorders each year. Anxiety disorders are America’s most common mental illness and are deemed highly treatable. The 63 percent of anxiety-plagued.

CBD 63

CBD Treatment Conditions Cannabis 63

Cannabis Law Report

SEPTEMBER 1, 2022

UK medical cannabis charity, Sapphire Medical Foundation, has secured new funding to support access to prescriptions during the cost-of-living crisis. . From Wednesday 31 August, UK and Channel Island residents can apply for a grant to fully support their medical cannabis prescription, in the second grant round of 2022.

Treatment 52

Treatment Chronic Pain Access Patients 52

The Cannigma

JULY 5, 2022

Cannabis regulation in Georgia is complicated, but the plant is still illegal. But it is a medical program in name only, because as of June 2022 there were no licensed dispensaries in Georgia. Several cities have decriminalized cannabis possession, but this is not statewide. Georgia’s medical cannabis program.

Law 96

Law Decriminalization Programs Patients 96

TheAnswerPage

JULY 19, 2022

Have researchers found that patients who use cannabidiol (CBD)-rich extract therapy for the treatment of epilepsy require a lower dose of CBD medication as compared to those who use purified CBD therapy for the treatment of epilepsy? Pamplona F, da Silva L and Coan A. 12 September 2018. Sec.Neuropharmacology. See the Answer.

Epilepsy 52

Epilepsy Therapy Extraction Data 52

Cannabis Law Report

AUGUST 23, 2021

The law, called “An Act to Control and Regulate Adult Use Cannabis,” would allow adults age 21 and older to buy, possess, grow and use marijuana. A 10% tax on marijuana sales would go to funding jobs, addiction treatment and community support for areas with marijuana businesses. Yost rejected a previous version on Aug.

Law 105

Law Legalization Treatment State Laws 105

TheAnswerPage

JULY 18, 2022

In 2017, researchers performed an analysis of observational studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products and reported on the side effects of the CBD products: “The reports of mild (158/216, 76% vs. 148/447, 33%, p. Pamplona F, da Silva L and Coan A.

Epilepsy 52

Epilepsy Therapy Extraction Treatment 52

The Cannigma

JULY 12, 2022

Roll out of the program has been slow, and as of June 2022, there were still no doctors certified to issue prescriptions, no licensed dispensaries, and no legal farming of cannabis products. Possible penalties for cannabis. Cannabis is still a deeply divisive subject in Alabama. Alabama medical cannabis program.

Legalization 122

Legalization Chronic Pain Programs Treatment 122

Canna Law Blog

DECEMBER 21, 2023

Welcome to the eighth annual “State of the State” post on Oregon cannabis. decrease from $994 million in 2022, which itself was the first calendar year cannabis sales contracted in Oregon. At this time in 2022, wholesale useable marijuana had been sitting at $600/lb for months, bottoming out at $550/lb for December.

Hemp 84

Hemp Retail Compliance Compliance 84

Cannabis Law Report

JUNE 9, 2022

Ukraine’s Health Minister Viktor Liashko announced on June 7 that the government had backed the bill that would legalize medical cannabis amid the war with Russia. We understand the number of people who will need medical treatment due to this exposure. “We understand the negative effects of war on mental health.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52